Vericel share price logo

Vericel

NASDAQ: VCEL

Mid Cap

$43.59

-0.61

(-1.37%)

as on

Vericel Stock Performance

as on August 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $43.41
    $44.31
    downward going graph

    0.41%

    Downside

    1.65%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $28.95
    $49.32
    downward going graph

    33.59%

    Downside

    13.15%

    Upside

    downward going graph

Vericel share price movements today

Previous Close
$44.20
Open
$44.14
Volume
242.3K
Market Cap
$2.3B
Day's Low - High
$43.41 - $44.31
52 Week Low - High
$28.95 - $49.32

Vericel Historical Returns

1 Month Return
-5.23 %
3 Month Return
+ 33.82 %
1 Year Return
+ 21.83 %
3 Year Return
+ 37.27 %
5 Year Return
-11.26 %

Vericel Stock Fundamentals & Key Indicators

Check Vericel market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3B

EPS (TTM)

0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

92.79

Industry PE ratio

-13.046547619047619

PEG Ratio

0.3820833333333334

EBITDA

38.5M

Revenue (TTM)

306.3M

Profit Margin

74.56%

Return On Equity TTM

6.91%

Vericel Stock Valuation

Track how Vericel P/E has moved over time to understand its valuation trends.

Vericel in the last 5 years

  • Overview

  • Trends

Lowest (-532.58x)

December 31, 2023

Industry (-13.05x)

December 31, 2025

Today (109.12x)

December 31, 2025

Highest (261.48x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 109.12x

Vericel vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Vericel image
Vericel
BUY$2.3B-11.26%92.7974.56%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Vericel Stock including INR - Dollar returns

The Vericel stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vericel investment value today

Current value as on today

₹1,31,544

Returns

₹31,544

(+31.54%)

Returns from Vericel Stock

₹20,149 (+20.15%)

Dollar Impact

₹11,396 (+11.4%)

Analyst Recommendation on Vericel Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Vericel. Average target price of $60.57

Vericel Share Price Target

Get share price movements and forecasts by analysts on Vericel.

What analysts predicted

28.03%UPSIDE

Target Price

$60.57

Current Price

$43.59

Analyzed by

4 Analysts

Target

$60.57

Vericel target price $60.57, a slight upside of 28.03% compared to current price of $43.59. According to 4 analysts rating.

Indian Investors' Interest in Vericel Stock

Search interest for Vericel Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

Vericel Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
51
52
57
75
52
63
67
92
68
77
Gross Profit
35
36
41
58
36
46
49
73
49
56
Operating Income
-5
-6
-2
18
-12
-2
3
22
-8
0
EBITDA
-2
-3
0
21
-8
2
8
27
-2
5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
2
2
2
3
3
3
Income Before Tax
-3
-4
0
19
-11
0
5
24
-6
2
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-3
-4
0
19
-11
0
5
23
-6
2
Net Profit Margin
68.94%
69.50%
71.93%
77.61%
68.96%
73.71%
73.46%
78.70%
72.00%
72.82%

Vericel Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
63
90
117
124
156
164
197
237
276
Gross Profit
33
58
80
84
106
109
135
172
205
Operating Income
-14
-3
-11
2
-7
-17
-6
4
11
EBITDA
-14
-4
-7
5
-4
-11
2
16
30
Interest Expense
1
1
0
0
0
0
0
0
1
Depreciation
1
1
1
2
2
3
4
5
11
Income Before Tax
-17
-8
-9
3
-7
-15
-2
10
17
Income Tax Expense
-
-
-
0
0
0
0
0
0
Net Income
-17
-8
-9
2
-7
-16
-3
10
16
Net Profit Margin
52.52%
64.60%
68.12%
67.83%
67.88%
66.80%
68.64%
72.55%
74.42%

Vericel Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-4
0
19
-11
0
5
23
-6
6
Operating Cash Flow
7
18
10
22
6
8
22
15
16
16
Investing Cash Flow
-25
-17
-21
-14
-15
-9
-3
-16
-4
-2
Financing Cash Flow
2
4
5
7
3
1
1
1
-2
1
Change in Cash
-16
5
-5
14
-5
0
19
0
9
14

Vericel Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-8
-9
2
-7
-16
-3
10
16
Operating Cash Flow
-13
0
-7
17
29
17
35
58
51
Investing Cash Flow
-1
-67
10
-17
-3
-36
-3
-79
-43
Financing Cash Flow
18
58
5
6
9
1
3
19
7
Change in Cash
3
-8
8
6
34
-17
35
-1
15

Mutual Funds that own Vericel Stock

Check out the Mutual Funds with significant holdings in Vericel.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
4.248613%
2175571
Conestoga Funds
3.05756%
1565673
IVY FUNDS
2.831784%
1450061
Professionally Managed Portfolios
1.954122%
1000640
Nationwide Mutual Funds
1.126469%
576827
See all

Global Institutional Holdings in Vericel

Funds
Holdings
iShares
11.93%
Vanguard
5.77%
SPDR
4.28%
Dimensional
0.9%
Invesco
0.69%
See all

Insights on Vericel

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -6.30M → 2.20M (in $), with an average increase of 385.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 68.42M → 77.45M (in $), with an average increase of 11.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, VCEL stock has moved up by 33.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 558.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 439.1%

About Vericel

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
OrganisationVericel
Headquarters25 Blue Sky Drive, Burlington, MA, United States, 01803
IndustryBiotechnology
CEOMr. Dominick C. Colangelo Esq.
E-voting on sharesClick here to vote

Key Management of Vericel

Name

Title

Mr. Dominick C. Colangelo Esq.

CEO, President & Director

Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.

Chief Medical Officer

Mr. Jonathan D. Siegal

Principal Accounting Officer, VP & Corporate Controller

Mr. Mike Gilligan

Senior Vice President of Sales

Mr. Patrick J. Fowler

Senior Vice President of Corporate Development & Strategy

Mr. Joseph Anthony Mara Jr.

CFO & Treasurer

Mr. Michael Halpin

Chief Operating Officer

Mr. Sean C. Flynn

Chief Legal Officer

Mr. Eric Burns

Vice President of Finance & Investor Relations

Mr. Roland DeAngelis

Chief Marketing Officer

FAQs

What is Vericel share price today?

Vericel share price today is $43.59 as on at the close of the market. Vericel share today touched a day high of $44.31 and a low of $43.41.

What is the 52 week high and 52 week low for Vericel share?

Vericel share touched a 52 week high of $49.32 on and a 52 week low of $28.95 on . Vericel stock price today i.e. is closed at $43.59,which is 11.62% down from its 52 week high and 50.57% up from its 52 week low.

What is Vericel's market capitalisation today?

Vericel market capitalisation is $0.00T as on .

How to invest in Vericel Stock (VCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vericel on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Shares that will get you 0.0344 shares as per Vericel share price of $43.59 per share as on August 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Vericel Stock (VCEL) from India?

Indian investors can start investing in Vericel (VCEL) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Vericel stock (as per the Rupee-Dollar exchange rate as on ). Based on Vericel share’s latest price of $43.59 as on August 18, 2026 at 1:29 am IST, you will get 0.2294 shares of Vericel. Learn more about fractional shares .

What are the returns that Vericel has given to Indian investors in the last 5 years?

Vericel stock has given -11.26% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?